Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01834196 · ClinicalTrials.gov registry record · NA

Swept-Source Optical Coherence Tomography for Noninvasive Retinal Vascular Imaging

A NA study, sponsored by Duke University.

Terminated
Registry status
NA
Development phase
13
Enrollment target

NCT01834196: Clinical Trial NA study, sponsored by Duke University.

NCT01834196 is a NA study that was terminated before completion, run by Duke University. The registered enrollment target is 13 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01834196, a NA study, was terminated before completion, sponsored by Duke University.

TERMINATED
Registry status
NA
Development phase
13 participants
Enrollment target

Study Summary

This is a clinical pilot study to assess the feasibility of using a swept-source optical coherence tomography (SSOCT) system to perform noninvasive imaging of the retinal vasculature in patients with existing microvascular disease.

Primary Outcome

Distributions, means, and standard deviations will be reported.

Interventions

  • DEVICE Swept-Source Optical Coherence Tomography

Trial Details

FieldValue
Enrollment Target 13 participants
Start Date 2012-08
Est. Completion 2012-11
Phase NA
Duke University

1,725 total trials

Why NCT01834196 stopped before completion

NCT01834196 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 13 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which Swept-Source Optical Coherence Tomography is the first listed.

NCT01834196 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01834196 about?

NCT01834196 is a clinical study titled "Swept-Source Optical Coherence Tomography for Noninvasive Retinal Vascular Imaging". This is a clinical pilot study to assess the feasibility of using a swept-source optical coherence tomography (SSOCT) system to perform noninvasive imaging of the retinal vasculature in patients with existing microvascular disease.

What is the current status of trial NCT01834196?

This trial is currently terminated. It is a NA study. The enrollment target is 13 participants. The study started on 2012-08. Estimated completion is 2012-11.

What interventions are being tested in trial NCT01834196?

The interventions under investigation include: Swept-Source Optical Coherence Tomography (DEVICE).

Who is sponsoring clinical trial NCT01834196?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01834196's enrollment target sits among peer trials

13 1911th of 2000 higher than 88 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03125655 · 13 participants

    Regulation of Inflammatory Genes in Psoriasis

  • NCT03774446 · 13 participants · Phase 2

    Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease

  • NCT03830151 · 13 participants · Phase 1

    Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors

  • NCT04573231 · 13 participants · Phase 2

    Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01834196, the US trial registry maintained by the National Library of Medicine. NCT01834196 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.